Core Viewpoint - The actual controller of Shenzhen Yuanwanggu Information Technology Co., Ltd., Xu Yusuo, plans to reduce his shareholding in the company, which has implications for the company's ownership structure and potential market reactions [2][3]. Group 1: Shareholding Changes - On December 19, 2025, Xu Yusuo announced intentions to reduce his shareholding by up to 22,192,722 shares, representing 3% of the total share capital [2]. - As of January 15 to January 22, 2026, Xu Yusuo reduced his holdings by 5,289,616 shares, bringing his total to 100,832,897 shares, which is 13.63% of the total share capital [3]. - On January 23, 2026, he further reduced his holdings by 3,031,303 shares, resulting in a total of 97,801,594 shares, or 13.22% of the total share capital [3]. Group 2: Pledge of Shares - As of January 23, 2026, the share pledge situation for Xu Yusuo and his concerted actor, Chen Guangzhu, indicates that 9,322,000 shares are pledged, which is 70.27% of their total holdings and 12.60% of the total share capital [5]. - The financing balance corresponding to the pledged shares is 29,490 million [5]. - There are currently no risks of forced liquidation or transfer of pledged shares, and the pledge risk is considered manageable [6].

每经AI快讯，福光股份1月26日晚间发布公告称，截至本公告披露日，福建福光股份有限公司持股5%以 上股东福建省国有资产管理有限公司持有公司股份约2928万股，占公司股份总数的18.24%。本次股份 质押后，国资公司持有公司股份累计质押数量（含本次）850万股，占其持有公司股份总数的29.03%， 占公司股份总数的5.29%。 每经头条（nbdtoutiao）——国际金价冲破5000美元！7年涨了280%，什么时候才见顶？专家：关键还 看美元，重点关注国际货币体系、降息和科技革命 （记者 张明双） ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:603569 证券简称:长久物流 公告编号：2026-002 北京长久物流股份有限公司 部分股份延期购回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 北京长久物流股份有限公司（以下简称"公司"）控股股东吉林省长久实业集团有限公司（以下简 称"长久集团"）持有公司股份371,240,533股，占公司总股本的61.51%；累计质押公司股份187,650,000 股，占其所持公司股份的50.55%，占公司总股本的31.09%。 ● 控股股东长久集团及其一致行动人上海汇瑾资产管理有限公司-汇瑾尊越1号私募证券投资基金（以下 简称"汇瑾尊越1号基金"）、上海牧鑫私募基金管理有限公司－牧鑫鼎泰1号私募证券投资基金（以下简 称"牧鑫鼎泰1号基金"）、新疆新长汇股权投资管理有限责任公司（以下简称"新长汇"）合计持有公司 股份428,859,005股，占公司总股本的71.06%；合计累计质押公司股187,650,000股，占所持公司股份的 43.76 ...

Group 1 - The company, Shenzhen Dashij Smart Co., Ltd., announced that its controlling shareholder, Changdu Dashij Enterprise Management (Group) Co., Ltd., has pledged part of its shares, totaling 3.8 million shares [1] - As of the announcement date, Changdu Dashij has cumulatively pledged 11.3 million shares, which accounts for 4.17% of its total holdings [1] - Liu Pang has cumulatively pledged 55.71 million shares, representing 61.06% of his total holdings [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 青岛英派斯健康科技股份有限公司（以下简称"公司"）近日接到控股股东海南江恒实业投资有限公司 （以下简称"海南江恒"）通知，获悉海南江恒所持有的本公司部分股份被质押，具体事项如下： 一、股东股份质押基本情况 （一）本次股份质押基本情况 ■ 本次质押股份不存在负担重大资产重组等业绩补偿义务。 （二）股东股份累计质押情况 截至公告披露日，海南江恒所持质押股份情况如下： ■ 注：本公告中"持股比例"、"占公司总股本比例"均未剔除公司回购专用账户中的股份数。 二、其他情况说明 截至本公告日，控股股东海南江恒质押的股份不存在平仓或被强制过户的风险，质押风险在可控范围之 内，上述质押行为不会导致公司实际控制权发生变更。如后续出现平仓风险，海南江恒将及时通知公司 披露相应的风险提示，并积极采取相关措施应对平仓风险。公司将持续关注其质押情况及质押风险情 况，并按规定及时做好相关信息披露工作，敬请投资者注意投资风险。 三、备查文件 1、中国证券登记结算有限责任公司出具的《证券质押及司 ...

Core Viewpoint - Shandong Luzhong Investment Co., Ltd. holds a 19.50% stake in Shandong Pharmaceutical Glass Co., Ltd., making it the controlling shareholder of the company [1] Group 1: Shareholding and Pledge Information - Luzhong Investment has pledged a total of 64,660,000 shares, which accounts for 9.74% of the company's total share capital and 49.98% of its holdings in the company [1] - The pledged shares are not used as collateral for major asset restructuring performance compensation or for other guarantee purposes [1]

Core Viewpoint - Qingdao Richen Food Co., Ltd. announced the pledge and release of shares by its controlling shareholder, Qingdao Boya Investment Holding Co., Ltd., indicating a stable financial situation and no significant impact on the company's operations or governance [2][4]. Group 1: Share Pledge Details - As of the announcement date, Qingdao Boya holds 48,810,000 shares of the company, accounting for 49.50% of the total share capital [2]. - The number of shares pledged this time is 3,900,000, while 4,780,000 shares have been released from pledge [2]. - After the pledge and release transactions, the total number of pledged shares by Qingdao Boya is 23,160,000, which represents 47.45% of its total holdings and 23.49% of the company's total share capital [2]. Group 2: Share Release Details - The announcement includes specific details regarding the release of pledged shares, although the exact figures are not provided in the summary [3]. Group 3: Shareholder Pledge Situation - The cumulative pledge situation of the controlling shareholder, Qingdao Boya, and the actual controller, Mr. Zhang Huajun, is outlined, indicating a well-managed pledge status [4]. Group 4: Other Situations - Qingdao Boya has a good credit status and repayment capability, with no current risk of forced liquidation or transfer of pledged shares [4]. - The share pledge will not lead to any change in the actual control of the company, nor will it significantly impact the company's operations or governance [4]. - The company will continue to monitor the pledge situation and comply with relevant disclosure obligations [4].

Core Viewpoint - The announcement from Magic Pharmaceuticals indicates a significant change in share pledges involving major shareholder Maijisi, which will not affect the company's control structure [1] Group 1: Share Pledge Details - On January 14, 2026, shareholder Maijisi will release and re-pledge 23.58 million shares, representing 4.42% of the company's total shares and 26.79% of Maijisi's holdings [1] - Maijisi currently holds 88.02 million shares, accounting for 16.48% of the total share capital, with a remaining pledged amount of 76.65 million shares, which is 14.35% of the total shares [1] - The controlling shareholder, Magic Holdings, along with Maijisi, collectively holds 179 million shares, which is 33.45% of the total share capital, with a cumulative pledge of 122 million shares, representing 22.84% of the total shares [1]

Group 1 - The core point of the announcement is that the major shareholder Wang Zhendong's 53,300,000 shares, accounting for 0.86% of the company's total share capital, have been forcibly sold due to a loan dispute, and this judicial disposal has been completed [1][2] - As of the announcement date, Wang Zhendong holds a total of 319,942,834 shares, representing 5.19% of the company's total share capital, and has cumulatively faced judicial enforcement on 142,500,000 shares, which is 2.31% of the total share capital [2] Group 2 - The shares involved in this judicial disposal originated from shares issued during a significant asset restructuring, and Wang Zhendong had previously committed to not transferring these shares for 24 months post-listing, which has now been fulfilled [3][4] - The judicial disposal will not significantly impact the company's governance structure, equity structure, or ongoing operations, nor will it lead to a change in control of the company [4]

Core Viewpoint - International Medical (000516) has experienced a significant stock price increase, closing at 6.19 yuan on January 14, 2026, marking a 9.95% rise and achieving consecutive trading limits for two days [1]. Trading Information Summary - On January 14, 2026, the net outflow of main funds was 171 million yuan, while retail investors saw a net inflow of 143 million yuan [3][7]. - International Medical was listed on the "Dragon and Tiger List" due to a cumulative price deviation of over 20% in the last three trading days, marking its first appearance on the list in the past five trading days [4][7]. Company Announcement Summary - The controlling shareholder, Shaanxi Century Xinyuan Commercial Management Co., Ltd., pledged 75 million shares to Chang'an International Trust Co., Ltd. on January 13, 2026. This pledge accounts for 12.17% of its holdings and 3.35% of the company's total share capital. After this pledge, the total pledged shares by Century Xinyuan reached 82.07% of its holdings, with a combined pledge by Century Xinyuan and its concerted actions amounting to 24.61% of the company's total share capital. The company stated that the pledge risk is controllable and will not lead to a change in actual control [5]. - The company confirmed that from January 12 to January 14, 2026, its stock price experienced a cumulative deviation exceeding 20%, constituting abnormal trading fluctuations. The company has verified that there are no undisclosed significant matters, and its operational situation remains normal. The controlling shareholder and actual controller did not trade the company's stock during this period. The company is not involved in the research, production, or sales of brain-computer interface products, and related application revenue has a minimal impact on its performance [6][7].